Talking Points

Episode 78: REDUCE-FMR: A Sham-Controlled Randomized Trial 18.09.2019 2:59 ↓

C. Michael Gibson sits down with Horst Sievert to learn more about the REDUCE-FMR trial.

Episode 77: PREPARE-CALC: High-speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation 04.09.2019 4:26 ↓

C. Michael Gibson gets the details on PREPARE-CALC from Gert Richardt.

Episode 76: Annapoorna Kini: Clinician, Researcher, Educator, and App Developer 22.08.2019 6:35 ↓

C. Michael Gibson learns more about Annapoorna Kini's work and why the field needs female role models.

Episode 75: CorMicA: A Randomized Trial of Invasive Coronary Function Testing 07.08.2019 8:14 ↓

C. Michael Gibson and Tom Ford discuss the potential for finding and treating patients with ANOCA.

Episode 74: Quality of Life in the COAPT Study 24.07.2019 8:36 ↓

C. Michael Gibson and David Cohen discuss adding years to life and adding life to years with the MitraClip.

Episode 73: COMPARE ABSORB 17.07.2019 2:10 ↓

C. Michael Gibson and Pieter Smits walk us through the COMPARE ABSORB trial.

Episode 72: NEOPRO: Nonrandomized Comparison of Two Transcatheter Heart Valves 03.07.2019 5:44 ↓

C. Michael Gibson and Azeem Latib take a closer look at some next-gen TAVR devices.

Episode 71: ULTIMATE: A Randomized Trial of Intravascular Ultrasound Guidance 18.06.2019 4:58 ↓

C. Michael Gibson and Junjie Zhang discuss ULTIMATE: A Randomized Trial of Intravascular Ultrasound Guidance of Coronary Drug-Eluting Stent Implantation in an All-Comers Patient Population.

Episode 70: FAST-FFR: Accuracy of Fractional Flow Reserve Derived From Coronary Angiography 05.06.2019 5:10 ↓

C. Michael Gibson and William Fearon talk FFR-CT.

Episode 69: SOLVE-TAVI: A 2x2 Randomized Trial of Transcather Aortic Valve Implantation 24.05.2019 7:07 ↓

C. Michael Gibson and Holger Thiele take a deep dive into a head-to-head trial of TAVR devices that also considered general versus local anesthesia.

Episode 68: TALENT: A Randomized Trial 15.05.2019 6:36 ↓

C. Michael Gibson talks with Patrick Serruys about, TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population."

Episode 67: RESET: Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents 01.05.2019 4:14 ↓

C. Michael Gibson and Hiroki Shiomi look at long-term outcomes from RESET.

Episode 66: PORTICO I: One-Year Outcomes 17.04.2019 3:31 ↓

C. Michael Gibson and Lars Sondergaard discuss 1-year outcomes in the PORTICO I trial.

Episode 65: SECURE-PCI: Impact of Timing of Atorvastatin Loading Dose 03.04.2019 4:58 ↓

Does timing of an atorvastatin loading dose make a difference in PCI for ACS? C. Michael Gibson and Renato Lopes discuss.

Episode 64: Building a New Backbone Upon Which to Randomize Patients: PERT Registry 20.03.2019 10:44 ↓

C. Michael Gibson, Kenneth Rosenfield, and Robert Lookstein discuss the way forward for PERT.

Episode 63: TRIVALVE: Evaluation of Edge-to-Edge Valve Repair 06.03.2019 3:57 ↓

C. Michael Gibson and Jörg Hausleiter discuss the TRIVALVE trial.

Episode 62: BIONYX: A Randomized Trial 20.02.2019 5:38 ↓

C. Michael Gibson and Clemens von Birgelen discuss the BIONYX randomized trial.

Episode 61: ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent 06.02.2019 3:30 ↓

C. Michael Gibson and Pieter Stella discuss ReCre8, which evaluated a polymer-free DES in an all-comers population.

Episode 60: What Do You Get When You Combine Twitter and a Textbook? Tweetbook 23.01.2019 3:44 ↓

What do you get when you combine Twitter and a textbook? C. Michael Gibson talks with Michael Savage and David Fischman.

Episode 59: IMPERIAL: A Randomized Trial of Drug-Eluting Stents 09.01.2019 3:29 ↓

C. Michael Gibson talks to William Gray about IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions.

Episode 58: 2018 North American Consensus Statement for Atrial Fibrilation Patients Undergoing PCI 02.01.2019 4:59 ↓

C. Michael Gibson speaks with Dominick Angiolillo about the 2018 North American Consensus Statement for Atrial Fibrilation Patients Undergoing PCI.

Episode 47: INTREPID 07.06.2018 3:43 ↓

Early results with a new device being developed for transcatheter MV replacement are promising, Paul Sorajja tells C. Michael Gibson.

Episode 46: DAPT-STEMI 18.05.2018 5:34 ↓

C. Michael Gibson gets the details from DAPT-STEMI from Elvin Kedhi.

Episode 34: TRACER 08.01.2018 4:58 ↓

TRACER: 6-Month Outcomes of Transcatheter MV Neochordal Repair in Patients With Severe Primary Mitral Regurgitation

Episode 35: TENDYNE Trial 08.01.2018 3:20 ↓

Dr. C. Michael Gibson talks to Dr. David W. M. Muller about TENDYNE: 1-Year Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Regurgitation